HEMICLOR Drug Patent Profile
When do Hemiclor patents expire, and when can generic versions of Hemiclor launch?
Hemiclor is a drug marketed by Prm Pharma and is included in one NDA. There is one patent protecting this drug.
The generic ingredient in HEMICLOR is chlorthalidone. There is one drug master file entry for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the chlorthalidone profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hemiclor
A generic version of HEMICLOR was approved as chlorthalidone by SUN PHARM INDUSTRIES on July 21st, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for HEMICLOR?
- What are the global sales for HEMICLOR?
- What is Average Wholesale Price for HEMICLOR?
Summary for HEMICLOR
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Patent Applications: | 4,063 |
| Drug Prices: | Drug price information for HEMICLOR |
| What excipients (inactive ingredients) are in HEMICLOR? | HEMICLOR excipients list |
| DailyMed Link: | HEMICLOR at DailyMed |
Pharmacology for HEMICLOR
| Drug Class | Thiazide-like Diuretic |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for HEMICLOR
HEMICLOR is protected by one US patents.
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prm Pharma | HEMICLOR | chlorthalidone | TABLET;ORAL | 218647-001 | Mar 17, 2025 | RX | Yes | Yes | 12,667,554 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
